Phase
Condition
Dementia
Diabetes Prevention
Diabetes And Hypertension
Treatment
HBOT intervention
Sham intervention
Clinical Study ID
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of T2D
Diagnosis of MCI
> the age of 65
Hebrew fluency
An informant
Exclusion
Exclusion Criteria:
Brain disease that affects cognition (e.g. Parkinson's disease, schizophrenia).
Stroke
Epilepsy
Chest pathology incompatible with HBOT
Inner ear disease
Claustrophobia
Cholinesterase inhibitors
Subjects with an indication for HBOT
Counter-indication for MRI or PET
Individuals with severe cataracts must have cataract operations before enrolling inthe study
Study Design
Study Description
Connect with a study center
Sheba Medical Center
Ramat Gan,
IsraelSite Not Available
Assaf HaRofeh Medical Center
Tzrifin, 70300
IsraelSite Not Available
Icahn School of Medicine at Mount Sinai
New York, New York 10029
United StatesSite Not Available
University of Wisconsin
Madison, Wisconsin 53076
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.